ANDA 75969, held by Pharmobedient. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 75969 (Metformin Hydrochloride), held by Pharmobedient, was first approved by FDA on Jan 29, 2002, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 29, 2002 | Original application | Approved | None posted |
| Metformin Hydrochloride500MG · tablet;oral | Metformin Hydrochloride | Discontinued |
| Metformin Hydrochloride850MG · tablet;oral | Metformin Hydrochloride | Discontinued |
| Metformin Hydrochloride1GM · tablet;oral | Metformin Hydrochloride | Discontinued |
| Aug 11, 2026 | Supplement 13Labeling · Standard review | Approved | None posted |
| Nov 14, 2019 | Supplement 11Labeling · Standard review | Approved | None posted |
| Nov 14, 2019 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jun 8, 2007 | Supplement 9Labeling | Approved | None posted |
| Jun 18, 2004 | Supplement 5Labeling | Approved | None posted |
| Jan 2, 2003 | Supplement 2Labeling | Approved | None posted |
| Nov 6, 2002 | Supplement 1Manufacturing | Approved | None posted |
| Jan 29, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters